CERA

Hope in sight TM

Our research is bringing hope to people affected by vision loss and blindness

Donate Now

Hope in Sight Giving Day

Join Jasmine in the fight for sight on Thursday 13 October in our third annual Hope in Sight Giving Day. Find out how you can triple your impact and raise vital funds for life-changing gene therapy research.

Event

Join Professor Robyn Guymer, Associate Professor Lyndell Lim and Associate Professor Peter van Wijngaarden on World Sight Day, 13 October, to discuss the latest in vision research.

EYE HEALTH RESOURCES

Our free guide gives you an essential introduction to age-related macular degeneration (AMD), and a snapshot of the latest research conducted at CERA.

Video

In this video, learn about CERA’s research into gene therapies that could halt or even reverse vision loss in patients with conditions such as inherited retinal diseases and glaucoma.

Donate to CERA

With your support, there’s hope in sight.

Your gift will contribute to our world-leading vision research, making a real difference to people affected by vision loss and blindness.

Donate now

Take part in research

We conduct world-leading clinical trials for a range of eye conditions.

Learn more about taking part in clinical trials for conditions like age-related macular degeneration, glaucoma, diabetic retinopathy and more.

Learn more

Latest News


Research

05 October 2022

Australians with inherited retinal disease (IRD) have a strong interest in undergoing gene therapy to prevent and treat blindness – but there’s a critical need for education programs to help them make informed choices about future treatments.

News

05 September 2022

A registry gathering vital information on people with inherited retinal diseases will help drive research into the most common cause of legal blindness in working-age Australians.

News

26 September 2022

Retinal gene therapy researchers Dr Tom Edwards and Dr Sloan Wang are developing a potential gene therapy to ‘melt’ the crystals on the retina which impair vision in people with Bietti’s Crystalline Dystrophy.

News

24 August 2022

New research links a person’s retinal appearance to Parkinson’s and cardiovascular disease risk.

Eye-news emails are sent to subscribers once a month

Newsletter Subscribe
Receive Appeals